News FDA approves first cell therapy for type 1 diabetes CellTrans has claimed the first FDA approval for a cell therapy used to treat type 1 diabetes, consisting of insulin-producing islet beta cells taken from deceased donors.
News Novo Nordisk, Aspect sign $2.6bn diabetes cell therapy deal Novo Nordisk has put $75 million down on the table to partner Canadian biotech Aspect Biosystems’ cell-based therapies for diabetes and obesity.
News UnitedHealth CEO Andrew Witty steps down Andrew Witty has resigned as CEO of US health conglomerate UnitedHealth, as the company pulled its financial forecasts for 2025.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.